Differential binding avidities of human IgM for staphylococcal protein A derive from specific germ-line VH3 gene usage

Human IgM that express the variable region genes of the VH3 family bind staphylococcal protein A (SPA). We previously reported that the SPA-binding IgM can be divided into two groups based on the differential binding avidities for solid-phase SPA. To study the molecular basis for these differences,...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 157; no. 7; pp. 2976 - 2981
Main Authors Hakoda, M, Kamatani, N, Hayashimoto-Kurumada, S, Silverman, GJ, Yamanaka, H, Terai, C, Kashiwazaki, S
Format Journal Article
LanguageEnglish
Published United States Am Assoc Immnol 01.10.1996
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Human IgM that express the variable region genes of the VH3 family bind staphylococcal protein A (SPA). We previously reported that the SPA-binding IgM can be divided into two groups based on the differential binding avidities for solid-phase SPA. To study the molecular basis for these differences, we cloned B cells from human blood by EBV transformation. The nucleotide sequences of the expressed Ig heavy chain genes were determined on 20 B cell clones that produce SPA-binding IgM. The germ-line VH3 gene usage in IgM with high avidities for SPA were distinct from the germ-line VH3 genes used in IgM with low avidities for SPA. There was no correlation in the usage of D or JH genes or in the usage of light chains in IgM according to the SPA binding avidity. These results suggest that the differential binding avidities for SPA are at least partly due to specific germ-line VH3 gene usage. An investigation of direct binding of SPA to the synthetic peptides corresponding to the portions of the variable regions of SPA-binding and non-SPA-binding IgM showed that the peptides corresponding to the VH3 family specific framework region 3 sequences had significant SPA binding capacities, while the peptides corresponding to the other subdomains and those corresponding to framework region 3 of the reported VH3 sequences from non-SPA-binding IgM showed little or no binding. It is of interest that the Ig-framework region 3 subdomain corresponds to the fourth hypervariable region, which in the TCR-beta chain has been implicated as a critical site for T cell superantigen binding.
AbstractList Human IgM that express the variable region genes of the VH3 family bind staphylococcal protein A (SPA). We previously reported that the SPA-binding IgM can be divided into two groups based on the differential binding avidities for solid-phase SPA. To study the molecular basis for these differences, we cloned B cells from human blood by EBV transformation. The nucleotide sequences of the expressed Ig heavy chain genes were determined on 20 B cell clones that produce SPA-binding IgM. The germ-line VH3 gene usage in IgM with high avidities for SPA were distinct from the germ-line VH3 genes used in IgM with low avidities for SPA. There was no correlation in the usage of D or JH genes or in the usage of light chains in IgM according to the SPA binding avidity. These results suggest that the differential binding avidities for SPA are at least partly due to specific germ-line VH3 gene usage. An investigation of direct binding of SPA to the synthetic peptides corresponding to the portions of the variable regions of SPA-binding and non-SPA-binding IgM showed that the peptides corresponding to the VH3 family specific framework region 3 sequences had significant SPA binding capacities, while the peptides corresponding to the other subdomains and those corresponding to framework region 3 of the reported VH3 sequences from non-SPA-binding IgM showed little or no binding. It is of interest that the Ig-framework region 3 subdomain corresponds to the fourth hypervariable region, which in the TCR-beta chain has been implicated as a critical site for T cell superantigen binding.
Human IgM that express the variable region genes of the VH3 family bind staphylococcal protein A (SPA). We previously reported that the SPA-binding IgM can be divided into two groups based on the differential binding avidities for solid-phase SPA. To study the molecular basis for these differences, we cloned B cells from human blood by EBV transformation. The nucleotide sequences of the expressed Ig heavy chain genes were determined on 20 B cell clones that produce SPA-binding IgM. The germ-line VH3 gene usage in IgM with high avidities for SPA were distinct from the germ-line VH3 genes used in IgM with low avidities for SPA. There was no correlation in the usage of D or J sub(H) genes or in the usage of light chains in IgM according to the SPA binding avidity. These results suggest that the differential binding avidities for SPA are at least partly due to specific germ-line VH3 gene usage. An investigation of direct binding of SPA to the synthetic peptides corresponding to the portions of the variable regions of SPA-binding and non-SPA-binding IgM showed that the peptides corresponding to the VH3 family specific framework region 3 sequences had significant SPA binding capacities, while the peptides corresponding to the other subdomains and those corresponding to framework region 3 of the reported VH3 sequences from non-SPA-binding IgM showed little or no binding. It is of interest that the Ig framework region 3 subdomain corresponds to the fourth hypervariable region, which in the TCR- beta chain has been implicated as a critical site for T cell superantigen binding.
Abstract Human IgM that express the variable region genes of the VH3 family bind staphylococcal protein A (SPA). We previously reported that the SPA-binding IgM can be divided into two groups based on the differential binding avidities for solid-phase SPA. To study the molecular basis for these differences, we cloned B cells from human blood by EBV transformation. The nucleotide sequences of the expressed Ig heavy chain genes were determined on 20 B cell clones that produce SPA-binding IgM. The germ-line VH3 gene usage in IgM with high avidities for SPA were distinct from the germ-line VH3 genes used in IgM with low avidities for SPA. There was no correlation in the usage of D or JH genes or in the usage of light chains in IgM according to the SPA binding avidity. These results suggest that the differential binding avidities for SPA are at least partly due to specific germ-line VH3 gene usage. An investigation of direct binding of SPA to the synthetic peptides corresponding to the portions of the variable regions of SPA-binding and non-SPA-binding IgM showed that the peptides corresponding to the VH3 family specific framework region 3 sequences had significant SPA binding capacities, while the peptides corresponding to the other subdomains and those corresponding to framework region 3 of the reported VH3 sequences from non-SPA-binding IgM showed little or no binding. It is of interest that the Ig-framework region 3 subdomain corresponds to the fourth hypervariable region, which in the TCR-beta chain has been implicated as a critical site for T cell superantigen binding.
Author Yamanaka, H
Terai, C
Silverman, GJ
Kamatani, N
Hayashimoto-Kurumada, S
Kashiwazaki, S
Hakoda, M
Author_xml – sequence: 1
  fullname: Hakoda, M
– sequence: 2
  fullname: Kamatani, N
– sequence: 3
  fullname: Hayashimoto-Kurumada, S
– sequence: 4
  fullname: Silverman, GJ
– sequence: 5
  fullname: Yamanaka, H
– sequence: 6
  fullname: Terai, C
– sequence: 7
  fullname: Kashiwazaki, S
BackLink https://www.ncbi.nlm.nih.gov/pubmed/8816405$$D View this record in MEDLINE/PubMed
BookMark eNqFUUtv1DAQtlBR2RZ-AULyCU5ZxnFsJ8eqBVqpiAtwtbzOOOsqsRc72VX_PV7tgrhxmsf30Gi-K3IRYkBC3jJYN9B0H5_8NC0hjmsm1Fqt607JF2TFhIBKSpAXZAVQ1xVTUr0iVzk_AYCEurkkl23LZANiRfZ33jlMGGZvRrrxofdhoGbvez97zDQ6ul0mE-jD8JW6mGiezW77PEYbrS2KXYoz-kBvaI_J75G6FCead2i985YOmKZq9AHpz3teptIs2Qz4mrx0Zsz45lyvyY_Pn77f3leP37483N48VrZRzVwZ1zIuWatA1L2tGRey6bpagXWs7ZhSfQOdqGHjGAD2LQcnjIKGG3RlseHX5P3Jt9z5a8E868lni-NoAsYla9VyLoRk_yUyUV4m2iORn4g2xZwTOr1LfjLpWTPQx1j0n1iKRmmlj7EU1buz_bKZsP-rOedQ8A8nfOuH7cEn1Hky41jYTB8Oh3-cfgO6Jpo1
CitedBy_id crossref_primary_10_1084_jem_189_8_1217
crossref_primary_10_1128_spectrum_03309_22
crossref_primary_10_1016_j_rvsc_2015_03_019
crossref_primary_10_1084_jem_20052033
crossref_primary_10_4049_jimmunol_161_12_6681
crossref_primary_10_1016_S0022_0248_01_01172_1
crossref_primary_10_1016_S0167_5699_97_01101_8
crossref_primary_10_1016_j_chroma_2015_06_064
crossref_primary_10_1007_s00281_004_0190_2
crossref_primary_10_3390_polym10070778
crossref_primary_10_1006_cimm_1998_1288
crossref_primary_10_7124_bc_000531
crossref_primary_10_1016_j_molimm_2004_07_013
crossref_primary_10_1111_j_1600_065X_1998_tb01428_x
crossref_primary_10_1007_s11626_012_9523_y
crossref_primary_10_1021_bi9920174
crossref_primary_10_1074_jbc_M111_330043
crossref_primary_10_1016_S0167_5699_98_80006_6
crossref_primary_10_1073_pnas_97_10_5399
crossref_primary_10_1016_S0161_5890_99_00085_1
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7T5
8FD
C1K
FR3
H94
P64
RC3
7X8
DOI 10.4049/jimmunol.157.7.2976
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Bacteriology Abstracts (Microbiology B)
Immunology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Genetics Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Genetics Abstracts
MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1550-6606
EndPage 2981
ExternalDocumentID 10_4049_jimmunol_157_7_2976
8816405
www157_7_2976
Genre Research Support, U.S. Gov't, P.H.S
Comparative Study
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: AI34001
GroupedDBID -
08R
2WC
34G
39C
3O-
53G
55
5GY
5RE
79B
85S
8RP
AALRV
AARDX
ABEFU
ABFLS
ABOCM
ABPPZ
ABPTK
ACGFS
ACIWK
ACNCT
ACPRK
ADKFC
AENEX
AETEA
AFFNX
AFRAH
AJYGW
ALMA_UNASSIGNED_HOLDINGS
D0L
DIK
DU5
EBS
EJD
F5P
FH7
FRP
G8K
GJ
HR
IH2
J5H
K-O
L7B
MVM
MYA
NEJ
OK1
P0W
P2P
PQEST
PQQKQ
R.V
RHF
RHI
RZQ
SJN
TWZ
VH1
WH7
WOQ
X
X7M
XFK
ZA5
ZE2
ZGI
ZXP
---
-~X
.55
.GJ
.HR
18M
ABCQX
ABJNI
ACGFO
ADNWM
AFHIN
AFOSN
AHWXS
AI.
AIZAD
CGR
CUY
CVF
ECM
EIF
GX1
NPM
XSW
XTH
AAYXX
CITATION
7QL
7T5
8FD
ABDPE
C1K
FR3
H94
P64
RC3
7X8
ID FETCH-LOGICAL-c474t-af8136187052dc21356499270cf189177d409520bf100ed830f5a7043aef00eb3
ISSN 0022-1767
IngestDate Fri Oct 25 08:20:17 EDT 2024
Fri Oct 25 22:14:54 EDT 2024
Thu Sep 26 16:59:26 EDT 2024
Sat Sep 28 07:35:19 EDT 2024
Tue Nov 10 19:20:46 EST 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c474t-af8136187052dc21356499270cf189177d409520bf100ed830f5a7043aef00eb3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://journals.aai.org/jimmunol/article-pdf/157/7/2976/1074217/2976.pdf
PMID 8816405
PQID 15881581
PQPubID 23462
PageCount 6
ParticipantIDs proquest_miscellaneous_78335561
proquest_miscellaneous_15881581
crossref_primary_10_4049_jimmunol_157_7_2976
pubmed_primary_8816405
highwire_smallpub1_www157_7_2976
ProviderPackageCode RHF
RHI
PublicationCentury 1900
PublicationDate 19961001
1996-Oct-01
1996-10-01
PublicationDateYYYYMMDD 1996-10-01
PublicationDate_xml – month: 10
  year: 1996
  text: 19961001
  day: 01
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of immunology (1950)
PublicationTitleAlternate J Immunol
PublicationYear 1996
Publisher Am Assoc Immnol
Publisher_xml – name: Am Assoc Immnol
SSID ssj0006024
Score 1.6823833
Snippet Human IgM that express the variable region genes of the VH3 family bind staphylococcal protein A (SPA). We previously reported that the SPA-binding IgM can be...
Abstract Human IgM that express the variable region genes of the VH3 family bind staphylococcal protein A (SPA). We previously reported that the SPA-binding...
SourceID proquest
crossref
pubmed
highwire
SourceType Aggregation Database
Index Database
Publisher
StartPage 2976
SubjectTerms Adult
Amino Acid Sequence
Antibodies, Bacterial - genetics
Antibodies, Bacterial - immunology
Antibodies, Bacterial - metabolism
Antibody Affinity
Antigens, Bacterial - immunology
Base Sequence
Gene Rearrangement, B-Lymphocyte, Heavy Chain
Genes, Immunoglobulin
Humans
Immunoglobulin Heavy Chains - genetics
Immunoglobulin M - genetics
Immunoglobulin M - immunology
Immunoglobulin M - metabolism
Immunoglobulin Variable Region - genetics
Infant, Newborn
Molecular Sequence Data
Sequence Alignment
Sequence Homology, Amino Acid
Sequence Homology, Nucleic Acid
Staphylococcal Protein A - immunology
Staphylococcal Protein A - metabolism
Staphylococcus
Staphylococcus aureus - immunology
Title Differential binding avidities of human IgM for staphylococcal protein A derive from specific germ-line VH3 gene usage
URI http://www.jimmunol.org/cgi/content/abstract/157/7/2976
https://www.ncbi.nlm.nih.gov/pubmed/8816405
https://search.proquest.com/docview/15881581
https://search.proquest.com/docview/78335561
Volume 157
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECXcFClyCdq0Qd104aE9uVJJSRTlY9AlSgL3lBS-CdQWBLWlIJFrpN_ZD-oMSVmykaDLRTAEiab4noYzo1kIecu9Ik95loNZAq9bIIR0VODlzjjkYeqpSPEIk5MnX8P4PDiZiulg8KsXtbRoUjf7eWdeyf-gCucAV8yS_QdkV4PCCfgN-MIREIbjX2H8yXY3adDtnV6aBBUMUtdlUrUeqH30xxcTHU4ImiCsKmxfdYbQ6BoN6O8Y5TBbLP-NuSaYe4nxQ6MLENqO1kK_xT62Wi5GCwxD6-uzXWaZKT6B2SamqtM7_e2M9TwNsfpe52rNA3uqQGE2XaW6b0KxusUOT8Ch2jldXMMTmLu6hmGXGM5tXbdHJ53jQsc6tyFwlmpzw8DR8Xxe1bO-kAb7mEvTpcMtrFwWYOWGLFwT3Ka0tWWo7IvhsWkqs7k_BGAP4f5gV8OFEVzpbl4NIF_NNWWiCKxJJrq9so0P2NhCV4GNy-USxkxkgmM-IA89EH8od4-mXeBRyLygrWGPj2lqYeHUPtwxsR2ybWexrjm11azvt4y0hnT2mOxaGtBDw9MnZFBUe2TbNDu93SOPJjaM4yn50ScutcSlK-LSuqSauBSIS4G4dJ241BKXHlJDXIrEpS1x6Yq4FIhLkbhUE_cZOf_y-exj7NgGIE4WyKBxVBlxP-SwpQgvzzzuixAMdE-yrOTRmEuZB2AheCwtOWNFHvmsFEqywFdFCSdSf59sVXVVPCc0ZWUacZUpJUosGQh2ASvzcRrmTKhC-EPyvl3c5MrUeUnAPkZUkhaVpIN2SGgLQHIzV7MZLDxP1tAfkjctMAmIbPwOp6qiXtzAMICoiPj9V0hMhQTLZkj2DaKrOVkuvPjz_x-Qne6te0m2mutF8QoU6CZ9rfn4G0tuxfk
link.rule.ids 315,783,787,27936,27937
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differential+binding+avidities+of+human+IgM+for+staphylococcal+protein+A+derive+from+specific+germ-line+VH3+gene+usage&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Hakoda%2C+M&rft.au=Kamatani%2C+N&rft.au=Hayashimoto-Kurumada%2C+S&rft.au=Silverman%2C+GJ&rft.date=1996-10-01&rft.pub=Am+Assoc+Immnol&rft.issn=0022-1767&rft.eissn=1550-6606&rft.volume=157&rft.issue=7&rft.spage=2976&rft_id=info:doi/10.4049%2Fjimmunol.157.7.2976&rft_id=info%3Apmid%2F8816405&rft.externalDBID=n%2Fa&rft.externalDocID=www157_7_2976
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon